Viramune and cytolytic hepatitis Patient Reports February 11, 2012

Viramune Side Effects Report #5011321-6
Viramune side effect was reported by a Physician from FRANCE on Mar 05, 2006. Female patient, weighting 165.3 lb, was diagnosed with immunodeficiency and was treated with Viramune. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, interstitial lung disease. Viramune dosage: unknown. During the same period patient was treated with KALETRA. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #4729992-8
Viramune side effect was reported by a Physician from FRANCE on June 17, 2005. Female patient, 51 years of age, was diagnosed with hiv infection , phlebitis and was treated with Viramune. After drug was administered, patient experienced the following side effects: cytolytic hepatitis. Viramune dosage: unknown. During the same period patient was treated with PREVISCAN, COMBIVIR. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #5140652-4
Viramune side effect was reported by a Physician from FRANCE on Oct 09, 2006. Male patient, 50 years of age, weighting 163.1 lb, was diagnosed with hiv infection  and was treated with Viramune. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cytolytic hepatitis, gamma-glutamyltransferase increased, white blood cell count decreased. Viramune dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #4628165-7
Viramune side effect was reported by a Consumer or non-health professional from on Mar 18, 2005. Female patient, 40 years of age, was diagnosed with hiv infection  and was treated with Viramune. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, fatigue, hyperlactacidaemia, mitochondrial cytopathy. Viramune dosage: unknown. During the same period patient was treated with EPIVIR, ZERIT, LEVOTHYROXINE, TRANDATE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.


Viramune Side Effects Report #5807875-X
Viramune side effect was reported by a Physician from on July 03, 2008. Female patient, 34 years of age, was diagnosed with hiv infection  and was treated with Viramune. After drug was administered, patient experienced the following side effects: cholestasis, cytolytic hepatitis, eczema . Viramune dosage: unknown. During the same period patient was treated with TRUVADA. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #4547225-2
Viramune side effect was reported by a Health Professional from on Dec 03, 2004. Male patient, 29 years of age, was diagnosed with hiv infection  and was treated with Viramune. After drug was administered, patient experienced the following side effects: bacterial infection , cough, cytolytic hepatitis, lung disorder, pyrexia. Viramune dosage: 400 MG (200 MG) PO. During the same period patient was treated with KALETRA, DEROXAT, TERCIAN, HAVLANE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #4600290-6
Viramune side effect was reported by a Consumer or non-health professional from on Feb 17, 2005. Female patient, 27 years of age, was diagnosed with hiv infection  and was treated with Viramune. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, lymphadenopathy, pruritus. Viramune dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #5065957-7
Viramune side effect was reported by a Consumer or non-health professional from FRANCE on Dec 03, 1999. Male patient, weighting 185.2 lb, was diagnosed with hiv infection  and was treated with Viramune. After drug was administered, patient experienced the following side effects: blood phosphorus decreased, cytolytic hepatitis, dysphagia, haematocrit decreased, haemoglobin decreased, heart rate increased, hepatitis cholestatic, hepatotoxicity. Viramune dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #5390664-0
Viramune side effect was reported by a Consumer or non-health professional from on July 06, 2007. Female patient, weighting 136.7 lb, was diagnosed with hiv infection  and was treated with Viramune. After drug was administered, patient experienced the following side effects: asthenia, cytolytic hepatitis, headache , hyperthermia, inflammation, jaundice , myalgia, pruritus. Viramune dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.


Viramune Side Effects Report #5404543-3
Viramune side effect was reported by a Consumer or non-health professional from on July 25, 2007. Female patient, weighting 136.7 lb, was diagnosed with hiv infection  and was treated with Viramune. After drug was administered, patient experienced the following side effects: asthenia, c-reactive protein increased, cytolytic hepatitis, headache , hyperthermia, jaundice , myalgia, pruritus. Viramune dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #5420201-3
Viramune side effect was reported by a Consumer or non-health professional from on Aug 13, 2007. Female patient, weighting 136.7 lb, was diagnosed with hiv infection  and was treated with Viramune. After drug was administered, patient experienced the following side effects: asthenia, c-reactive protein increased, cytolytic hepatitis, headache , hyperthermia, jaundice , myalgia, pruritus. Viramune dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #5447953-0
Viramune side effect was reported by a Consumer or non-health professional from FRANCE on Aug 30, 2007. Female patient, weighting 136.7 lb, was diagnosed with hiv infection  and was treated with Viramune. After drug was administered, patient experienced the following side effects: asthenia, c-reactive protein increased, cytolytic hepatitis, headache , hyperthermia, jaundice , myalgia, pruritus. Viramune dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #5527130-5
Viramune side effect was reported by a Consumer or non-health professional from FRANCE on Nov 19, 2007. Female patient, weighting 136.7 lb, was diagnosed with hiv infection  and was treated with Viramune. After drug was administered, patient experienced the following side effects: asthenia, c-reactive protein increased, cytolytic hepatitis, headache , hyperthermia, jaundice , myalgia, pruritus. Viramune dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #6012539-6
Viramune side effect was reported by a Health Professional from on Dec 11, 2008. Male patient was diagnosed with hiv infection , hepatitis b , hypertension, myocardial ischaemia and was treated with Viramune. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, dyspnoea, rash maculo-papular, renal failure. Viramune dosage: 400MG. During the same period patient was treated with TRUVADA, KARDEGIC, PLAVIX, CARVEDILOL. Patient was hospitalized. Patient recovered.


Viramune Side Effects Report #6018597-7
Viramune side effect was reported by a Health Professional from on Dec 19, 2008. Male patient was diagnosed with hiv infection , hepatitis b , hypertension, myocardial ischaemia and was treated with Viramune. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, dyspnoea, rash maculo-papular, renal failure. Viramune dosage: 400MG. During the same period patient was treated with TRUVADA, KARDEGIC, PLAVIX, CARVEDILOL. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #6049263-X
Viramune side effect was reported by a Health Professional from on Jan 15, 2009. Male patient was diagnosed with hiv infection , hepatitis b , hypertension, myocardial ischaemia and was treated with Viramune. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, dyspnoea, eosinophilia, rash maculo-papular, renal failure. Viramune dosage: 400MG. During the same period patient was treated with TRUVADA, KARDEGIC, PLAVIX, CARVEDILOL. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #6106396-7
Viramune side effect was reported by a Health Professional from on Feb 12, 2009. Male patient was diagnosed with hiv infection , hepatitis b , hypertension, myocardial ischaemia and was treated with Viramune. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, dyspnoea, eosinophilia, rash maculo-papular, renal failure. Viramune dosage: 400MG. During the same period patient was treated with TRUVADA, ASPIRIN, PLAVIX, KREDEX. Patient was hospitalized. Patient recovered.

Viramune Side Effects Report #5170431-3
Viramune side effect was reported by a Consumer or non-health professional from FRANCE on Oct 30, 2000. Male patient, weighting 167.6 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with Viramune. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, eosinophilia, hypersensitivity, pyrexia, rash . Viramune dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized and became disabled. Patient recovered.

Viramune Side Effects Report #4945938-1
Viramune side effect was reported by a Physician from FRANCE on Mar 05, 2006. Male patient, 40 years of age, was treated with Viramune. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, lung disorder. Viramune dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.